ERAAs for menopause treatment: Welcome the 'designer estrogens'
Estrogen receptor agonist-antagonists (ERAAs) selectively inhibit or stimulate estrogen-like action in targeted tissues. This review summarizes how ERAAs can be used in combination with an estrogen or alone to treat menopausal symptoms (vasomotor symptoms, genitourinary syndrome of menopause), breas...
Gespeichert in:
| Veröffentlicht in: | Cleveland Clinic journal of medicine 2017-06, Vol.84 (6), p.463-470 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 470 |
|---|---|
| container_issue | 6 |
| container_start_page | 463 |
| container_title | Cleveland Clinic journal of medicine |
| container_volume | 84 |
| creator | Hirsch, Heather D Shih, Elim Thacker, Holly L |
| description | Estrogen receptor agonist-antagonists (ERAAs) selectively inhibit or stimulate estrogen-like action in targeted tissues. This review summarizes how ERAAs can be used in combination with an estrogen or alone to treat menopausal symptoms (vasomotor symptoms, genitourinary syndrome of menopause), breast cancer or the risk of breast cancer, osteopenia, osteoporosis, and other female midlife concerns. |
| doi_str_mv | 10.3949/ccjm.84a.15140 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1911703212</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1911703212</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335t-a469b7a2d7447cede1428d7791d563b8f604d43594b38c75dbc3de38276347c03</originalsourceid><addsrcrecordid>eNo9kEtLAzEQx4MotlavHmVv9bJrXrtJvEgp9QEFQRSPIZvM1pZ91GT34LdvaqunYWb-D_ghdE1wxhRXd9Zumkxyk5GccHyCxkQxlVJZqFM0xlKRlJAcj9BFCBuMaU6oOkej-KeSUzlGD4u32SwkVeeTBtpua4YASe_B9HHt75NPqG3XxNMXJFMHYb1qwScQet-toA3TS3RWmTrA1XFO0Mfj4n3-nC5fn17ms2VqGcv71PBClcJQJzgXFhyQ2O6EUMTlBStlVWDuOMsVL5m0InelZQ6YpKJg0YDZBN0ecre--x5iv27WwUJdmxa6IWiiCBGYUUKjNDtIre9C8FDprV83xv9ogvUemt5D0xGa_oUWDTfH7KFswP3L_yixHRIkZwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1911703212</pqid></control><display><type>article</type><title>ERAAs for menopause treatment: Welcome the 'designer estrogens'</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hirsch, Heather D ; Shih, Elim ; Thacker, Holly L</creator><creatorcontrib>Hirsch, Heather D ; Shih, Elim ; Thacker, Holly L</creatorcontrib><description>Estrogen receptor agonist-antagonists (ERAAs) selectively inhibit or stimulate estrogen-like action in targeted tissues. This review summarizes how ERAAs can be used in combination with an estrogen or alone to treat menopausal symptoms (vasomotor symptoms, genitourinary syndrome of menopause), breast cancer or the risk of breast cancer, osteopenia, osteoporosis, and other female midlife concerns.</description><identifier>ISSN: 0891-1150</identifier><identifier>EISSN: 1939-2869</identifier><identifier>DOI: 10.3949/ccjm.84a.15140</identifier><identifier>PMID: 28628428</identifier><language>eng</language><publisher>United States</publisher><subject>Bone Diseases, Metabolic - drug therapy ; Breast Neoplasms - drug therapy ; Drug Therapy, Combination ; Estrogens - pharmacology ; Female ; Hot Flashes - drug therapy ; Humans ; Menopause - physiology ; Selective Estrogen Receptor Modulators - pharmacology ; Treatment Outcome</subject><ispartof>Cleveland Clinic journal of medicine, 2017-06, Vol.84 (6), p.463-470</ispartof><rights>Copyright © 2017 Cleveland Clinic.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c335t-a469b7a2d7447cede1428d7791d563b8f604d43594b38c75dbc3de38276347c03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28628428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirsch, Heather D</creatorcontrib><creatorcontrib>Shih, Elim</creatorcontrib><creatorcontrib>Thacker, Holly L</creatorcontrib><title>ERAAs for menopause treatment: Welcome the 'designer estrogens'</title><title>Cleveland Clinic journal of medicine</title><addtitle>Cleve Clin J Med</addtitle><description>Estrogen receptor agonist-antagonists (ERAAs) selectively inhibit or stimulate estrogen-like action in targeted tissues. This review summarizes how ERAAs can be used in combination with an estrogen or alone to treat menopausal symptoms (vasomotor symptoms, genitourinary syndrome of menopause), breast cancer or the risk of breast cancer, osteopenia, osteoporosis, and other female midlife concerns.</description><subject>Bone Diseases, Metabolic - drug therapy</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Drug Therapy, Combination</subject><subject>Estrogens - pharmacology</subject><subject>Female</subject><subject>Hot Flashes - drug therapy</subject><subject>Humans</subject><subject>Menopause - physiology</subject><subject>Selective Estrogen Receptor Modulators - pharmacology</subject><subject>Treatment Outcome</subject><issn>0891-1150</issn><issn>1939-2869</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLAzEQx4MotlavHmVv9bJrXrtJvEgp9QEFQRSPIZvM1pZ91GT34LdvaqunYWb-D_ghdE1wxhRXd9Zumkxyk5GccHyCxkQxlVJZqFM0xlKRlJAcj9BFCBuMaU6oOkej-KeSUzlGD4u32SwkVeeTBtpua4YASe_B9HHt75NPqG3XxNMXJFMHYb1qwScQet-toA3TS3RWmTrA1XFO0Mfj4n3-nC5fn17ms2VqGcv71PBClcJQJzgXFhyQ2O6EUMTlBStlVWDuOMsVL5m0InelZQ6YpKJg0YDZBN0ecre--x5iv27WwUJdmxa6IWiiCBGYUUKjNDtIre9C8FDprV83xv9ogvUemt5D0xGa_oUWDTfH7KFswP3L_yixHRIkZwQ</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Hirsch, Heather D</creator><creator>Shih, Elim</creator><creator>Thacker, Holly L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201706</creationdate><title>ERAAs for menopause treatment: Welcome the 'designer estrogens'</title><author>Hirsch, Heather D ; Shih, Elim ; Thacker, Holly L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335t-a469b7a2d7447cede1428d7791d563b8f604d43594b38c75dbc3de38276347c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Bone Diseases, Metabolic - drug therapy</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Drug Therapy, Combination</topic><topic>Estrogens - pharmacology</topic><topic>Female</topic><topic>Hot Flashes - drug therapy</topic><topic>Humans</topic><topic>Menopause - physiology</topic><topic>Selective Estrogen Receptor Modulators - pharmacology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirsch, Heather D</creatorcontrib><creatorcontrib>Shih, Elim</creatorcontrib><creatorcontrib>Thacker, Holly L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cleveland Clinic journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirsch, Heather D</au><au>Shih, Elim</au><au>Thacker, Holly L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ERAAs for menopause treatment: Welcome the 'designer estrogens'</atitle><jtitle>Cleveland Clinic journal of medicine</jtitle><addtitle>Cleve Clin J Med</addtitle><date>2017-06</date><risdate>2017</risdate><volume>84</volume><issue>6</issue><spage>463</spage><epage>470</epage><pages>463-470</pages><issn>0891-1150</issn><eissn>1939-2869</eissn><abstract>Estrogen receptor agonist-antagonists (ERAAs) selectively inhibit or stimulate estrogen-like action in targeted tissues. This review summarizes how ERAAs can be used in combination with an estrogen or alone to treat menopausal symptoms (vasomotor symptoms, genitourinary syndrome of menopause), breast cancer or the risk of breast cancer, osteopenia, osteoporosis, and other female midlife concerns.</abstract><cop>United States</cop><pmid>28628428</pmid><doi>10.3949/ccjm.84a.15140</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0891-1150 |
| ispartof | Cleveland Clinic journal of medicine, 2017-06, Vol.84 (6), p.463-470 |
| issn | 0891-1150 1939-2869 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1911703212 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Bone Diseases, Metabolic - drug therapy Breast Neoplasms - drug therapy Drug Therapy, Combination Estrogens - pharmacology Female Hot Flashes - drug therapy Humans Menopause - physiology Selective Estrogen Receptor Modulators - pharmacology Treatment Outcome |
| title | ERAAs for menopause treatment: Welcome the 'designer estrogens' |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A35%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ERAAs%20for%20menopause%20treatment:%20Welcome%20the%20'designer%20estrogens'&rft.jtitle=Cleveland%20Clinic%20journal%20of%20medicine&rft.au=Hirsch,%20Heather%20D&rft.date=2017-06&rft.volume=84&rft.issue=6&rft.spage=463&rft.epage=470&rft.pages=463-470&rft.issn=0891-1150&rft.eissn=1939-2869&rft_id=info:doi/10.3949/ccjm.84a.15140&rft_dat=%3Cproquest_cross%3E1911703212%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1911703212&rft_id=info:pmid/28628428&rfr_iscdi=true |